Selected article for: "acute sars respiratory syndrome and adjacent membrane"

Author: Wong, Louise H.; Edgar, James R.; Martello, Andrea; Ferguson, Brian J.; Eden, Emily R.
Title: Exploiting Connections for Viral Replication
  • Cord-id: 6f4v3vyb
  • Document date: 2021_3_18
  • ID: 6f4v3vyb
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the COVID-19 (coronavirus disease 2019) pandemic, is a positive strand RNA (+RNA) virus. Like other +RNA viruses, SARS-CoV-2 is dependent on host cell metabolic machinery to survive and replicate, remodeling cellular membranes to generate sites of viral replication. Viral RNA-containing double-membrane vesicles (DMVs) are a striking feature of +RNA viral replication and are abundant in SARS-CoV-2–infected cells. Their g
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the COVID-19 (coronavirus disease 2019) pandemic, is a positive strand RNA (+RNA) virus. Like other +RNA viruses, SARS-CoV-2 is dependent on host cell metabolic machinery to survive and replicate, remodeling cellular membranes to generate sites of viral replication. Viral RNA-containing double-membrane vesicles (DMVs) are a striking feature of +RNA viral replication and are abundant in SARS-CoV-2–infected cells. Their generation involves rewiring of host lipid metabolism, including lipid biosynthetic pathways. Viruses can also redirect lipids from host cell organelles; lipid exchange at membrane contact sites, where the membranes of adjacent organelles are in close apposition, has been implicated in the replication of several +RNA viruses. Here we review current understanding of DMV biogenesis. With a focus on the exploitation of contact site machinery by +RNA viruses to generate replication organelles, we discuss evidence that similar mechanisms support SARS-CoV-2 replication, protecting its RNA from the host cell immune response.

    Search related documents:
    Co phrase search for related documents
    • adaptor protein and low density: 1
    • adaptor protein and low density lipoprotein: 1
    • adaptor protein and lysosomal targeting: 1
    • low density and lung carcinoma: 1
    • low density and lung tissue: 1, 2, 3, 4, 5, 6, 7
    • low density and lysosome fusion: 1
    • low density and machine learning: 1, 2
    • low density lipoprotein and lung tissue: 1, 2, 3
    • low density lipoprotein and lysosome fusion: 1
    • low density lipoprotein and machine learning: 1
    • lung carcinoma and machine learning: 1, 2, 3
    • lung carcinoma and machine learning model: 1
    • lung tissue and lysosome fusion: 1
    • lung tissue and machine learning: 1, 2, 3, 4, 5, 6
    • lung tissue and machine learning model: 1